Title:Role of Nanoformulations in the Treatment of Lung Cancer
Volume: 18
Author(s): Parijat Pandey, Gunjan Nautiyal, Deepika Purohit, Sneh lata, Virender Kumar, Manish Makhija, Deeksha Manchanda, Neha Minocha, Sunil Kumar and Deepak Kaushik*
Affiliation:
- Department of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak – 124001, Haryana, India
Keywords:
Nanotechnology, Lung Cancer, Diagnosis, Patents, Clinical Trials
Abstract: Lung cancer is the second deadliest disease in the world. A major portion of deaths related to cancer are due to lung cancer in both males and females. Interestingly, unbelievable advances
have occurred in recent years through the use of nanotechnology and development in both the diagnosis and treatment of lung cancer. Due to their in vivo stability, the nanotechnology-based pharmacological system gained huge attractiveness, solubility, absorption from the intestine, pharmacological effectiveness, etc. of various anticancer agents. However, this field needs to be utilized more to
get maximum results in the treatment of lung cancer, along with wider context medicines. In the
present review, authors have tried to concentrate their attention on lung cancer`s difficulties along
with the current pharmacological and diagnostic situation, and current advancements in approaches
based on nanotechnology for the treatment and diagnosis of lung cancer. While nanotechnology offers these promising avenues for lung cancer diagnosis and treatment, it is important to acknowledge
the need for careful evaluation of safety, efficacy, and regulatory approval. With continued research
and development, nanotechnology holds tremendous potential to revolutionize the management of
lung cancer and improve patient outcomes. The review also highlights the involvement of endocrine
systems, especially estrogen in lung cancer proliferation. Some of the recent clinical trials and patents on nanoparticle-based formulations that have applications in the treatment and diagnosis of
lung cancer are also discussed.
